Concurrent use of aromatase inhibitors and hypofractionated radiation therapy

doi:10.4329/wjr.v4.i7.318

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4126)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

398

HTML

3319

Figures (1-1)

211

Tables (1-4)

198

Sum=4126

Jul 28, 2012 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Radiology

ISSN

1949-8470

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Radiol. Jul 28, 2012; 4(7): 318-323
Published online Jul 28, 2012. doi: 10.4329/wjr.v4.i7.318

Open in New Tab Full Size Figure Download Figure

Figure 1 Evolution of the probability of presenting fibrosis according to the time delays after hypofractionated radiotherapy. HFRT: Hypofractionated radiotherapy.

Citation: Chargari C, Castro-Pena P, Toledano I, Bollet MA, Savignoni A, Cottu P, Laki F, Campana F, Fourquet A, Kirova YM. Concurrent use of aromatase inhibitors and hypofractionated radiation therapy. World J Radiol 2012; 4(7): 318-323
URL: https://www.wjgnet.com/1949-8470/full/v4/i7/318.htm
DOI: https://dx.doi.org/10.4329/wjr.v4.i7.318